quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:00:31·800d
INSIDERFiling
CURO Group Holdings Corp. logo

Schulz Tamara L covered exercise/tax liability with 1,699 shares, decreasing direct ownership by 2% to 90,523 units (SEC Form 4)

CURO· CURO Group Holdings Corp.
Finance
Original source

Companies

  • CURO
    CURO Group Holdings Corp.
    Finance

Recent analyst ratings

  • Feb 7UpdateJefferies-
  • Feb 24UpdateCredit Suisse$4.00
  • Nov 3UpdateJanney-
  • Jul 26UpdateJefferies$15.00
  • Dec 30UpdateCredit Suisse$26.00
  • Dec 30UpdateJefferies$25.00

Related

  • SEC755d
    SEC Form 15-12G filed by CURO Group Holdings Corp.
  • SEC756d
    SEC Form EFFECT filed by CURO Group Holdings Corp.
  • SEC759d
    CURO Group Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR759d
    CURO Group Holdings Corp. to Reduce Debt and Strengthen Financial Position Through Restructuring Support Agreement; Implements Prepackaged Restructuring Plan by Commencing Voluntary Chapter 11 Reorganization
  • SEC765d
    CURO Group Holdings Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • SEC769d
    CURO Group Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR769d
    CURO Group Holdings Corp. Enters Forbearance Agreement Amendments and Waiver Amendment to Allow for Continued Constructive Discussions with Lenders and Stakeholders
  • SEC770d
    SEC Form 25-NSE filed by CURO Group Holdings Corp.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022